Overview Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Status: Completed Trial end date: 2012-06-01 Target enrollment: Participant gender: Summary The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS). Phase: Phase 2 Details Lead Sponsor: Laboratoires TheaCollaborators: KeyrusKeyrus BiopharmaVEEDATreatments: AzithromycinOphthalmic SolutionsPovidoneTetrahydrozoline